These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

665 related items for PubMed ID: 19941409

  • 1. Recent advances in intravenous delivery of poorly water-soluble compounds.
    Shi Y, Porter W, Merdan T, Li LC.
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1261-82. PubMed ID: 19941409
    [Abstract] [Full Text] [Related]

  • 2. Biopharmaceutical challenges associated with drugs with low aqueous solubility--the potential impact of lipid-based formulations.
    O'Driscoll CM, Griffin BT.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):617-24. PubMed ID: 18155800
    [Abstract] [Full Text] [Related]

  • 3. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A, Hoffman A.
    J Control Release; 2008 Jul 02; 129(1):1-10. PubMed ID: 18499294
    [Abstract] [Full Text] [Related]

  • 4. Developing early formulations: practice and perspective.
    Li P, Zhao L.
    Int J Pharm; 2007 Aug 16; 341(1-2):1-19. PubMed ID: 17658228
    [Abstract] [Full Text] [Related]

  • 5. Drug delivery strategies for poorly water-soluble drugs: the industrial perspective.
    van Hoogevest P, Liu X, Fahr A.
    Expert Opin Drug Deliv; 2011 Nov 16; 8(11):1481-500. PubMed ID: 21895540
    [Abstract] [Full Text] [Related]

  • 6. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S, Leveiller F, Franchi D, de Jong H, Lindén H.
    Eur J Pharm Sci; 2007 Aug 16; 31(5):249-61. PubMed ID: 17616376
    [Abstract] [Full Text] [Related]

  • 7. Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.
    Kawabata Y, Wada K, Nakatani M, Yamada S, Onoue S.
    Int J Pharm; 2011 Nov 25; 420(1):1-10. PubMed ID: 21884771
    [Abstract] [Full Text] [Related]

  • 8. Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives.
    Shegokar R, Müller RH.
    Int J Pharm; 2010 Oct 31; 399(1-2):129-39. PubMed ID: 20674732
    [Abstract] [Full Text] [Related]

  • 9. Application of drug delivery technologies in lead candidate selection and optimization.
    Chaubal MV.
    Drug Discov Today; 2004 Jul 15; 9(14):603-9. PubMed ID: 15239979
    [Abstract] [Full Text] [Related]

  • 10. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P, Morelli A, Pezzetta D, Rocchetti M, Poggesi I.
    Eur J Pharm Sci; 2007 Nov 15; 32(3):169-81. PubMed ID: 17714921
    [Abstract] [Full Text] [Related]

  • 11. Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology.
    Merisko-Liversidge E, Liversidge GG.
    Adv Drug Deliv Rev; 2011 May 30; 63(6):427-40. PubMed ID: 21223990
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. In vitro methods to assess drug precipitation.
    Dai WG.
    Int J Pharm; 2010 Jun 30; 393(1-2):1-16. PubMed ID: 20347943
    [Abstract] [Full Text] [Related]

  • 14. Prodrug strategies to overcome poor water solubility.
    Stella VJ, Nti-Addae KW.
    Adv Drug Deliv Rev; 2007 Jul 30; 59(7):677-94. PubMed ID: 17628203
    [Abstract] [Full Text] [Related]

  • 15. Pharmaceutical applications of cyclodextrins: basic science and product development.
    Loftsson T, Brewster ME.
    J Pharm Pharmacol; 2010 Nov 30; 62(11):1607-21. PubMed ID: 21039545
    [Abstract] [Full Text] [Related]

  • 16. Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters.
    Bittner B, Mountfield RJ.
    Curr Opin Drug Discov Devel; 2002 Jan 30; 5(1):59-71. PubMed ID: 11865674
    [Abstract] [Full Text] [Related]

  • 17. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs.
    Kawakami K.
    Adv Drug Deliv Rev; 2012 May 01; 64(6):480-95. PubMed ID: 22265844
    [Abstract] [Full Text] [Related]

  • 18. Approaches for the development of solid and semi-solid lipid-based formulations.
    Jannin V, Musakhanian J, Marchaud D.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):734-46. PubMed ID: 18045728
    [Abstract] [Full Text] [Related]

  • 19. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP, Chaubal MV, Shorr R.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):757-67. PubMed ID: 18096269
    [Abstract] [Full Text] [Related]

  • 20. Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.
    Dai WG, Pollock-Dove C, Dong LC, Li S.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):657-72. PubMed ID: 18222563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.